Dudediligence.

REGENXBIO Inc

RGNXNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Price
FilingsNewest: 8-K, Material agreementSep 23 →InsidersNo open-market buys. 2 insiders sold $484,373, all 3 sales on a 10b5-1 plan.→HoldersBlackRock 11.8%Redmile 8.1%State Street 5.5%→Financing →PeersClosest companies: DNLI, LXEO, PASG→

From the filings

Figures

Revenue
$174.5Mlast 12 months
Net income
−$196.4Mlast 12 months
Operating cash flow
−$233.8Mlast 12 months
Cash and equivalents
$36.5Mat the last balance sheet
Shares outstanding
54.2M shareson issue
Every year and quarter →